Signaling pathways
-
F1581 Anti-Integrin aV/ITGAV/CD51 Antibody (Abituzumab)Summary: Anti-Integrin aV/ITGAV/CD51 Antibody (Abituzumab) -
F1582 Anti-Integrin aVb6 (ITGAV & ITGB6) Antibody (STX-100)Summary: Anti-Integrin aVb6 (ITGAV & ITGB6) Antibody (STX-100) -
F1583 Anti-Integrin b1/ITGB1/CD29 Antibody (OS2966)Summary: Anti-Integrin b1/ITGB1/CD29 Antibody (OS2966) -
F1584 Anti-ICAM1/CD54 Antibody (Bersanlimab)Summary: Anti-ICAM1/CD54 Antibody (Bersanlimab) -
F1585 Anti-Integrin b2/ITGB2/CD18 Antibody (Erlizumab)Summary: Anti-Integrin b2/ITGB2/CD18 Antibody (Erlizumab) -
F1586 Anti-Integrin a5b1 (ITGA5 & ITGB1) Antibody (Volociximab)Summary: Anti-Integrin a5b1 (ITGA5 & ITGB1) Antibody (Volociximab) -
F1587 Anti-GPR44/PTGDR2/CD294 Antibody (KHK patent anti-CRTH2)Summary: Anti-GPR44/PTGDR2/CD294 Antibody (KHK patent anti-CRTH2) -
F1588 Anti-Histone H3 Antibody (Immunomedics patent anti-Histone H3)Summary: Anti-Histone H3 Antibody (Immunomedics patent anti-Histone H3) -
F1589 Anti-OX2R/CD200R1 Antibody (Janssen patent anti-CD200R1)Summary: Anti-OX2R/CD200R1 Antibody (Janssen patent anti-CD200R1) -
F1590 Anti-PAR2 Antibody (PAR650097)Summary: Anti-PAR2 Antibody (PAR650097)